Overview

Clinical Study to Compare Efficacy and Safety of Indinol Forto 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis

Status:
RECRUITING

Trial end date:
2026-11-01

Target enrollment:

Participant gender:

Summary

Prospective open-label randomized parallel groups study to compare efficacy and safety of Indinol Forto 200 mg capsules and Visanne 2 mg tablets in treatment of endometriosis. This is phase 3 study, based on hypothesis of non-inferiority.

Phase:

PHASE3

Details

Lead Sponsor:

Alcea

Treatments:

dienogest
indole-3-carbinol